Inventiva S.A. (EPA:IVA)
4.630
-0.100 (-2.11%)
Sep 12, 2025, 5:35 PM CET
Inventiva Revenue
In the year 2024, Inventiva had annual revenue of 14.09M EUR, down -38.24%. Inventiva had revenue of 11.36M in the half year ending December 31, 2024, a decrease of -26.34%.
Revenue
14.09M
Revenue Growth
-38.24%
P/S Ratio
45.70
Revenue / Employee
121.50K
Employees
118
Market Cap
644.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.09M | -8.73M | -38.24% |
Dec 31, 2023 | 22.82M | 4.77M | 26.41% |
Dec 31, 2022 | 18.05M | 9.55M | 112.35% |
Dec 31, 2021 | 8.50M | 3.24M | 61.52% |
Dec 31, 2020 | 5.26M | -6.03M | -53.39% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.40B |
Inventiva News
- 8 days ago - Inventiva to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 9 days ago - Today's Analyst Rating: Inventiva (IVA) Receives 'Buy' Rating from HC Wainwright & Co. ... - GuruFocus
- 10 days ago - Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
- 16 days ago - Inventiva surges as Piper Sandler issues bullish view citing lead asset - Seeking Alpha
- 4 weeks ago - Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 6 weeks ago - Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux - GlobeNewsWire
- 2 months ago - Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance - GlobeNewsWire
- 2 months ago - Inventiva receives $10 million milestone payment from CTTQ - GlobeNewsWire